NFKB1 and colitis: Regarding quinic acid, one study 402 showed that this compound attenuated UC by inhibiting the TLR4-NF-κB and NF-κB-iNOS-NO signaling pathways, thereby reducing colitis-related complications such as oxidative stress, inflammation, apoptosis, and histopathological damage in the same animal models.